122 related articles for article (PubMed ID: 18248391)
21. Hyperthermic intraperitoneal chemotherapy with oxaliplatin as treatment for peritoneal carcinomatosis arising from the appendix and pseudomyxoma peritonei: a survival analysis.
Marcotte E; Dubé P; Drolet P; Mitchell A; Frenette S; Leblanc G; Leclerc YE; Sideris L
World J Surg Oncol; 2014 Nov; 12():332. PubMed ID: 25380618
[TBL] [Abstract][Full Text] [Related]
22. Pseudomyxoma peritonei: the 'controversial' disease.
Galani E; Marx GM; Steer CB; Culora G; Harper PG
Int J Gynecol Cancer; 2003; 13(4):413-8. PubMed ID: 12911716
[TBL] [Abstract][Full Text] [Related]
23. Significance of epithelial cell clusters in pseudomyxoma peritonei.
Badyal RK; Khairwa A; Rajwanshi A; Nijhawan R; Radhika S; Gupta N; Dey P
Cytopathology; 2016 Dec; 27(6):418-426. PubMed ID: 27121698
[TBL] [Abstract][Full Text] [Related]
24. Pseudomyxoma peritonei of a mature ovarian teratoma caused by mismatch repair deficiency in a patient with Lynch syndrome: a case report.
Gohda Y; Noguchi R; Horie T; Igari T; Nakamura H; Ohta Y; Yamaguchi K; Ikenoue T; Hatakeyama S; Yusa N; Furukawa Y; Yano H
BMC Med Genet; 2016 Dec; 17(1):94. PubMed ID: 27938333
[TBL] [Abstract][Full Text] [Related]
25. Pseudomyxoma peritonei: role of 18F-FDG PET in preoperative evaluation of pathological grade and potential for complete cytoreduction.
Passot G; Glehen O; Pellet O; Isaac S; Tychyj C; Mohamed F; Giammarile F; Gilly FN; Cotte E
Eur J Surg Oncol; 2010 Mar; 36(3):315-23. PubMed ID: 19818580
[TBL] [Abstract][Full Text] [Related]
26. [Pseudomyxoma peritonei: report of 11 cases with a literature review].
Dong Y; Li T; Zou W; Liang Y
Zhonghua Bing Li Xue Za Zhi; 2002 Dec; 31(6):522-5. PubMed ID: 12622904
[TBL] [Abstract][Full Text] [Related]
27. Pseudomyxoma peritonei: unusual origin from an ovarian mature cystic teratoma.
Pranesh N; Menasce LP; Wilson MS; O'Dwyer ST
J Clin Pathol; 2005 Oct; 58(10):1115-7. PubMed ID: 16189164
[TBL] [Abstract][Full Text] [Related]
28. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.
Sugarbaker PH
Eur J Surg Oncol; 2001 Apr; 27(3):239-43. PubMed ID: 11373099
[TBL] [Abstract][Full Text] [Related]
29. A Patient With a Low-grade Mucinous Neoplasm Involving the Ovary and Pseudomyxoma Peritonei Originating in an Isolated Intestinal Duplication.
Simons M; Ebisch I; de Hullu J; van Ham M; Snijders M; de Kievit I; Bulten J
Int J Gynecol Pathol; 2018 Jul; 37(4):338-343. PubMed ID: 28700427
[TBL] [Abstract][Full Text] [Related]
30. Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Smeenk RM; Verwaal VJ; Antonini N; Zoetmulder FA
Ann Surg; 2007 Jan; 245(1):104-9. PubMed ID: 17197972
[TBL] [Abstract][Full Text] [Related]
31. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei and appendix tumours in elderly patients: Is it justified?
López-López V; Cascales-Campos PA; Gil E; Arevalo J; Gonzalez A; Gil J; Muñoz-Casares FC; Melero JT; Barrios P; Morales R; Ramos I; Ortega G; Camps B; González-Bayón L; Bretcha-Boix P; Farré-Alegre J; González-Moreno S; Parrilla P
Clin Transl Oncol; 2017 Nov; 19(11):1388-1392. PubMed ID: 28812240
[TBL] [Abstract][Full Text] [Related]
32. Kras mutations and p53 overexpression in pseudomyxoma peritonei: association with phenotype and prognosis.
Shetty S; Thomas P; Ramanan B; Sharma P; Govindarajan V; Loggie B
J Surg Res; 2013 Mar; 180(1):97-103. PubMed ID: 23199549
[TBL] [Abstract][Full Text] [Related]
33. A rare case of pseudomyxoma peritonei presenting an unusual inguinal hernia and splenic metastasis.
Shimoyama S; Kuramoto S; Kawahara M; Yamasaki K; Endo H; Murakami T; Kaminishi M
J Gastroenterol Hepatol; 2001 Jul; 16(7):825-9. PubMed ID: 11446896
[TBL] [Abstract][Full Text] [Related]
34. Two independent primary mucinous tumors involving the appendix and ovary accompanied with acellular pseudomyxoma peritonei.
Zhou F; Chen X; Li Y; Huang L
Int J Clin Exp Pathol; 2015; 8(9):11831-4. PubMed ID: 26617936
[TBL] [Abstract][Full Text] [Related]
35. Drug Sensitivity Testing in Cytoreductive Surgery and Intraperitoneal Chemotherapy of Pseudomyxoma Peritonei.
Bjersand K; Mahteme H; Sundström Poromaa I; Andréasson H; Graf W; Larsson R; Nygren P
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S810-6. PubMed ID: 26193962
[TBL] [Abstract][Full Text] [Related]
36. [Pseudomyxoma peritonei].
Besznyák I; Pommersheim F; Tóth J
Orv Hetil; 1996 Dec; 137(50):2803-7. PubMed ID: 9679616
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Baratti D; Kusamura S; Martinetti A; Seregni E; Laterza B; Oliva DG; Deraco M
Ann Surg Oncol; 2007 Aug; 14(8):2300-8. PubMed ID: 17510772
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of complete cytoreductive surgery and two intraperitoneal chemotherapy techniques in Pseudomyxoma peritonei.
Sørensen O; Flatmark K; Reed W; Wiig JN; Dueland S; Giercksky KE; Larsen SG
Eur J Surg Oncol; 2012 Oct; 38(10):969-76. PubMed ID: 22763244
[TBL] [Abstract][Full Text] [Related]
39. [An analysis of pathologic features and prognostic factors of 10 cases with pseudomyxoma peritonei].
Zhou X; Du X
Zhonghua Fu Chan Ke Za Zhi; 1995 Sep; 30(9):543-6. PubMed ID: 8556915
[TBL] [Abstract][Full Text] [Related]
40. Identifying prognostic factors in Japanese women with pseudomyxoma peritonei: a retrospective clinico-pathological study of the Tohoku Gynecologic Cancer Unit.
Kojimahara T; Nakahara K; Shoji T; Sugiyama T; Takano T; Yaegashi N; Yokoyama Y; Mizunuma H; Tase R; Satou H; Tanaka T; Motoyama T; Kurachi H
Tohoku J Exp Med; 2011 Feb; 223(2):91-6. PubMed ID: 21263209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]